A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India

NCT06370715 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin Lispro-aabc
DRUG: Insulin Glargine

Sponsor

Eli Lilly and Company

Collaborators

[object Object]